These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21301020)

  • 1. The unfulfilled promise of efficacy trials in HIV/hepatitis C co-infected patients.
    Chandok N; John S; Haider S
    Ann Hepatol; 2011; 10(1):103-4. PubMed ID: 21301020
    [No Abstract]   [Full Text] [Related]  

  • 2. Risks and benefits of antiretroviral therapy in HIV-HCV co-infected patients.
    Núñez M; Soriano V
    J Hepatol; 2005 Mar; 42(3):290-2. PubMed ID: 15710208
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy.
    Landau A; Batisse D; Piketty C; Jian R; Kazatchkine MD
    AIDS; 2000 Aug; 14(12):1857-8. PubMed ID: 10985327
    [No Abstract]   [Full Text] [Related]  

  • 4. Advances in the pharmaceutical care of hepatitis C/HIV co-infection.
    Ogbuokiri T
    HIV Clin; 2005; 17(1):12-5. PubMed ID: 15754458
    [No Abstract]   [Full Text] [Related]  

  • 5. Trends in HIV care, Part 2: antiretrovirals in the pipeline, HIV/hepatitis C virus coinfection, and pharmacokinetics of treatment adherence--a roundtable discussion.
    Corales RB; Djeloski DS; Mancenido MD; Valenti WM
    AIDS Read; 2009 Feb; 19(2):62-4, 70-4, 78. PubMed ID: 19271330
    [No Abstract]   [Full Text] [Related]  

  • 6. Neuropsychiatric impact of hepatitis C on advanced HIV.
    Asnis GM; Migdal AL
    Neurology; 2005 Feb; 64(4):768; author reply 768. PubMed ID: 15728326
    [No Abstract]   [Full Text] [Related]  

  • 7. [Guidelines for the management of HCV infection in HIV-infected patients. Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani].
    Antonucci G; Antinori A; Boumis E; De Longis P; Gentile M; Girardi E; Lauria FN; Narciso P; Noto P; Palmieri F; Oliva A; Petrosillo N; Rosati S; Urso R; Tocci G; Tozzi V; Visco Comandini U; Ippolito G
    Infez Med; 2004 Mar; 12(1):7-18. PubMed ID: 15329524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatic transplantation in HIV-HCV co-infected patients].
    Gadano A; Aziz H; Macias S; Villamil F
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S70-3; discussion S74-82. PubMed ID: 16862868
    [No Abstract]   [Full Text] [Related]  

  • 9. Current treatment options for hepatitis C patients co-infected with HIV.
    Rockstroh JK; Hardy WD
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):689-95. PubMed ID: 26799571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between HIV-1 and HCV infections: towards a new entity?
    Winnock M; Salmon-Céron D; Dabis F; Chêne G
    J Antimicrob Chemother; 2004 Jun; 53(6):936-46. PubMed ID: 15117928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is time to treat for HCV all the HIV/HCV co-infected hemophiliacs?
    Franchini M
    Hematology; 2006 Jun; 11(3):209-13. PubMed ID: 17325964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Selection for treatment of hepatitis C co-infected patients for ].
    Findor J; Bessone F; Corti M
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S48-50; discussion S74-82. PubMed ID: 16862860
    [No Abstract]   [Full Text] [Related]  

  • 13. Providers face big challenge: HIV/HCV co-infection. Hepatitis B infection also problematic.
    AIDS Alert; 2006 Aug; 21(8):85-7. PubMed ID: 16913040
    [No Abstract]   [Full Text] [Related]  

  • 14. IFN-alpha: therapeutic options in HIV and HIV/HCV, HIV/HBV dual infection.
    Jablonowski H
    Infection; 2003 Mar; 31(2):131-3. PubMed ID: 12749300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update 2015.
    Antinori A; Marcotullio S; Andreoni M; Chirianni A; d'Arminio Monforte A; Di Biagio A; Galli M; Mazzotta F; Mussini C; Puoti M; Lazzarin A;
    New Microbiol; 2016 Apr; 39(2):93-109. PubMed ID: 27196547
    [No Abstract]   [Full Text] [Related]  

  • 16. Side effects. Safety and effectiveness of interferon and ribavirin in HIV+ people co-infected with hepatitis C virus.
    TreatmentUpdate; 2001; 12(8):4-5. PubMed ID: 12132439
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapeutic aspects of human immunodeficiency virus, hepatitis B and C coinfection].
    Bani-Sadr F
    Gastroenterol Clin Biol; 2003 May; 27(5):528-33. PubMed ID: 12843917
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C-HIV coinfection: current and future therapy.
    Vyas JJ; Brown RS; Gaglio PJ
    Expert Rev Anti Infect Ther; 2003 Oct; 1(3):433-9. PubMed ID: 15482140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of HIV-HCV and HBV-HCV co-infection].
    Jmelnitzky AC; Jorge O; Manero E
    Acta Gastroenterol Latinoam; 2005 Jun; 35 Suppl 1():S46-8. PubMed ID: 20214301
    [No Abstract]   [Full Text] [Related]  

  • 20. New paradigms in the management of hepatitis C virus co-infections.
    Sherman KE
    Nat Clin Pract Gastroenterol Hepatol; 2007 Jan; 4 Suppl 1():S10-6. PubMed ID: 17235280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.